R406(游离的)

• 常用名: R406(游离的)
• 英文名: R406 (free base)
• CAS号: 841290-80-0
• 分子量: 470.454
• 密度: 1.4±0.1 g/cm3
• 沸点: N/A
• 分子式: C₂₂H₂₃FN₆O₅
• 熔点: N/A
• 闪点: N/A

R406(游离的)用途

R406是Syk抑制剂,IC50为41 nM,对Lyn活性较弱。

R406(游离的)名称

• 中文名: 6-[[5-氟-2-[(3,4,5-三甲氧基苯基)氨基]-4-嘧啶基]氨基]-2,2-二甲基-2H-吡啶并[3,2-b]-1,4-噁嗪-3(4H)-酮
• 英文名: 6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]amino]-2,2-dimethyl-4H-pyrido[3,2-b][1,4]oxazin-3-one
• 中文别名: R406(游离的)

R406(游离的)生物活性

• 描述: R406是Syk抑制剂,IC50为41 nM,对Lyn活性较弱。
• 相关类别:
  信号通路 >> 蛋白酪氨酸激酶 >> SYK
  研究领域 >> 炎症/免疫
• 参考文献:

  [1]. Braselmann S, et al. R406, an orally available spleen tyrosine kinase inhibitor blocks fc receptor signaling and reduces immune complex-mediated inflammation. J Pharmacol Exp Ther, 2006, 319(3), 998-1008.

  [2]. Quiroga MP, et al. B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406. Blood, 2009, 114(5), 1029-1037.

  [3]. Lhermusier T, et al. The Syk-kinase inhibitor R406 impairs platelet activation and monocyte tissue factor expression triggered by heparin-PF4 complex directed antibodies. J Thromb Haemost, 2011, 9(10), 2067-2076.

  [4]. Zhu Y, et al. Immunotoxicity assessment for the novel Spleen tyrosine kinase inhibitor R406. Toxicol Appl Pharmacol, 2007, 221(3), 268-277.

R406(游离的)物理化学性质

• 密度: 1.4±0.1 g/cm3
• 分子式: C₂₂H₂₃FN₆O₅
• 分子量: 470.454
• 精确质量: 470.171387
• PSA: 128.75000
• LogP: 4.32
• 折射率: 1.618
• 储存条件: -20°C

R406(游离的)英文别名

• N-Aminocytidine
• uridine,4-hydrazone
• 6-({5-Fluoro-2-[(3,4,5-trimethoxyphenyl)amino]-4-pyrimidinyl}amino)-2,2-dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one
• N4-aminocytidine minimum
• 2H-Pyrido[3,2-b]-1,4-oxazin-3(4H)-one, 6-[[5-fluoro-2-[(3,4,5-trimethoxyphenyl)amino]-4-pyrimidinyl]amino]-2,2-dimethyl-
• N4-NH2-Cr
• 6-({5-Fluoro-2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl}amino)-2,2-dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one
• compound 1007
• R406
• R-406